Sperm, Exposure and Endocrine Disruptors

Study acronym: SEED
StatusNot Yet Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Dec 2026 → Jun 2027
See other at-risk trials from Million Marker Wellness, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 15, 2026 to Nov 2026 Show 5 more changesShow less
    • Primary completion pushed from Dec 2026 to Jun 2027
    • Study completion pushed from Mar 2027 to Jun 2027
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 8 of 9 entries
    • Publications: details revised at 13 of 13 entries
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The proposed research aims to 1) measure male participants' urinary levels of EDCs and sperm quality before and after report-back and EDC reduction intervention and assess changes, 2) assess the extent to which MM's program (testing, curriculum, and report-back) alters participant environmental health literacy (EHL), readiness to change (RtC), and product/lifestyle choices, and 3) test the feasibility and acceptability of MM's program to male participants. The primary study subjects are adult men of reproductive age. The study aims to have 60 participants complete the study.
Trial Details
NCT Number NCT07703046
Lead Sponsor Million Marker Wellness, Inc.
Collaborators: Fellow Health, Inc., National Institute of Environmental Health Sciences (NIEHS)
Conditions
(from sponsor)		 Fertility, Male Fertility, Sperm Count, Low, Sperm Quality
Related terms Oligospermia
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov